ByTrending Posts
Can CMR Surgical’s AI-Driven Versius Platform Expand Access…
Executive Summary CMR Surgical, the global medical robotics innovator behind the Versius® surgical system, is advancing the integration…
Is Stryker Advancing AI-Enabled Surgical Platforms to Transform…
Executive Summary Stryker, a global leader in medical technology, is accelerating the integration of artificial intelligence, robotics, and…
Can Johnson & Johnson’s Verb Surgical and Ottava…
Executive Summary Johnson & Johnson’s surgical technology efforts—anchored in the Verb Surgical initiative and now evolving under the…
Can Medtronic’s AI-Enabled Devices Transform Outcomes Across Cardiac,…
Executive Summary Medtronic, a global leader in medical technology, is accelerating the integration of artificial intelligence and advanced…
Is Intuitive Surgical Advancing AI-Powered Robotic Surgery to…
Executive Summary Intuitive Surgical, a global pioneer in robotic assisted surgery, is accelerating the integration of artificial intelligence,…
Is Qure.ai Powering Real-World AI Applications Across Emergency,…
Executive Summary Qure.ai, a global leader in AI-powered medical imaging solutions, is advancing the adoption of clinical AI…
Can Lunit’s Diagnostic AI Translate Early Detection into…
Executive Summary Lunit, a global leader in AI-powered diagnostic imaging and decision support, has demonstrated accelerating adoption across…
Is Arterys Leading Cloud-Native AI in Medical Imaging…
Executive Summary Arterys, a pioneer in cloud-native medical imaging AI, is shaping the future of diagnostic workflows by…
Can Zebra Medical Vision (Zebra-AI) Drive Widespread Clinical…
Overview: Healthcare Intelligence Beyond Diagnostic Alerts Zebra Medical Vision (Zebra-AI) is emerging as a differentiated leader in AI-driven…
Trending Posts
Latest Stories
Can Angelini’s $120M AI Alliance with Quiver Bioscience Redefine Drug Discovery in Genetic Epilepsies?
Executive SummaryIn a strategic push to strengthen its neuroscience pipeline, Angelini Pharma has entered a…
Is Takeda’s $1.7B Bet on Iambic Therapeutics the Defining Moment for AI-Validated Drug Discovery?
Executive SummaryIn one of the largest AI-driven drug discovery collaborations to date, Takeda Pharmaceutical has…
Can Hippocratic AI’s Acquisition of Grove AI Trigger the Shift from Fragmented Pilots to a Unified Agentic AI Platform in Biopharma?
Executive SummaryAt the 2026 JPM Healthcare Conference in San Francisco, Hippocratic AI announced the acquisition…
Innovent and Eli Lilly Expand Strategic Alliance to Advance Immunology and Oncology Innovation
Shanghai, China – February, 2026 – Innovent Biologics Inc today announced a new strategic collaboration…
Gallery
